Patten Group’s Cantel Medical Corporation CMD Stock Holding History

Patten Group’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-85	Closed	-$8K	–	716
2018 Q3	$8K	Hold	85	–	–	﹤0.01%	556
2018 Q2	$8K	Buy	+85	New	+$9.51K	﹤0.01%	533

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Patten Group's CMD Position: Q4 2018 in Review

Patten Group sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 85 shares — an estimated $8K sold.

Patten Group first reported a position in CMD in Q2 2018 and held it in 2 quarters. The position peaked at $8K in Q3 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

Patten Group reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
Patten Group sold 85 Cantel Medical Corporation shares in Q4 2018, an estimated $8K.
Patten Group first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 2 quarters.
Patten Group's Cantel Medical Corporation position peaked at $8K in Q3 2018.
253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Patten Group's 13F filing for Q4 2018, filed 12 Feb 2019.